A Banner & Witcoff and BNA Webinar:
Practical Implications of Mayo v. Prometheus
On April 19, 2012, the lawyers of Banner & Witcoff; Drew Hirshfeld, Deputy Commissioner for Patent Examination Policy for the USPTO; Hans Saurer, Ph.D., Deputy General Counsel for Biotechnology Industry Organization, led a panel discussion that provided analysis and insight on the U.S. Supreme Court’s decision in Mayo v. Prometheus.
to view the 90-minute recorded program.
*Please note CLE credit is only available for attending the live event. Listening to a recording of the webinar does not qualify you for CLE credit.
This presentation provides analysis and insight on the U.S. Supreme Court’s highly anticipated ruling in Mayo v. Prometheus
involving patent eligibility of methods in the area of personalized medicine. Mayo
provoked more than 40 amicus briefs from organizations and companies including BIO, AIPLA, IPO, ACLU, Hewlett Packard, Verizon, Roche and Nine Law Professors. In this webinar, you will learn about the decision and its implications through reasoned analysis and thoughtful insights from a panel of experts from the biotech industry, private practice, and the U.S. Patent and Trademark Office. This webinar will provide key insight on evaluating your patent portfolio in light of this ruling, as well as a discussion of effective strategies for protecting intellectual property going forward.
- Gain an understanding of how Mayo v. Prometheus may affect existing patents.
- Learn the best strategies and practices to protect innovations in light of this decision.
- Learn how the USPTO is implementing the decision and training examiners.
- Gain expert insight as to what may lie ahead for patents in the life science area.
Please contact any of the presenters with your questions, or contact any Banner & Witcoff attorney for more information about the firm’s capabilities in this specialized area of law.
If you have technical difficulties with the webinar program file, please contact the webmaster at firstname.lastname@example.org.